Molecular Mechanism of Moderate Insulin Resistance in Adiponectin-Knockout Mice

この論文にアクセスする

この論文をさがす

著者

    • YANO WATARU
    • Department of Diabetes and Metabolic Disease, Graduate School of Medicine, University of Tokyo
    • KUBOTA NAOTO
    • Department of Diabetes and Metabolic Disease, Graduate School of Medicine, University of Tokyo
    • ITOH SHINSUKE
    • Department of Diabetes and Metabolic Disease, Graduate School of Medicine, University of Tokyo
    • KUBOTA TETSUYA
    • Department of Diabetes and Metabolic Disease, Graduate School of Medicine, University of Tokyo
    • AWAZAWA MOTOHARU
    • Department of Diabetes and Metabolic Disease, Graduate School of Medicine, University of Tokyo
    • MOROI MASAO
    • Division of Cardiovascular Medicine, Toho University, Ohashi Hospital
    • SUGI KAORU
    • Division of Cardiovascular Medicine, Toho University, Ohashi Hospital
    • TAKAMOTO ISEKI
    • Department of Diabetes and Metabolic Disease, Graduate School of Medicine, University of Tokyo
    • OGATA HITOMI
    • Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • TOKUYAMA KUMPEI
    • Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • NODA TETSUO
    • Department of Cell Biology, Japanese Foundation for Cancer Research-Cancer Institute
    • TERAUCHI YASUO
    • Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine
    • UEKI KOHJIRO
    • Department of Diabetes and Metabolic Disease, Graduate School of Medicine, University of Tokyo
    • KADOWAKI TAKASHI
    • Department of Diabetes and Metabolic Disease, Graduate School of Medicine, University of Tokyo

抄録

Adiponectin has been proposed to act as an antidiabetic adipokine, suppressing gluconeogenesis and stimulating fatty acid oxidation in the liver and skeletal muscle. Although adiponectin-knockout (adipo(-/-)) mice are known to exhibit insulin resistance, the degrees of insulin resistance and glucose intolerance are unexpectedly only moderate. In this study, the adipo(-/-) mice showed hepatic, but not muscle, insulin resistance. insulin-stimulated phosphorylation of IRS-1 and IRS-2 was impaired, the IRS-2 protein level was decreased, and insulin-stimulated phosphorylation of Akt was decreased in the liver of the adipo(-/-) mice. However, the triglyceride content in the liver was not increased in these mice, despite the decrease in the PPARalpha expression involved in lipid combustion, since the expressions of lipogenic genes such as SREBP-1 and SCD-1 were decreased in association with the increased leptin sensitivity. Consistent with this, the down-regulation SREBP-1 and SCD-1 observed in the adipo(-/-) mice was no longer observed, and the hepatic triglyceride content was significantly increased in the adiponectin leptin double-knockout (adipo(-/-)ob/ob) mice. On the other hand, the triglyceride content in the skeletal muscle was significantly decreased in the adipo(-/-) mice, probably due to up-regulated AMPK activity associated with the increased leptin sensitivity. In fact, these phenotypes in the skeletal muscle of these mice were no longer observed in the adipo(-/-)ob/ob mice. In conclusion, adipo(-/-) mice showed impaired insulin signaling in the liver to cause hepatic insulin resistance, however, no increase in the triglyceride content was observed in either the liver or the skeletal muscle, presumably on account of the increased leptin sensitivity.<br>

収録刊行物

  • Endocrine journal  

    Endocrine journal 55(3), 515-522, 2008-06-01 

    The Japan Endocrine Society

参考文献:  26件

参考文献を見るにはログインが必要です。ユーザIDをお持ちでない方は新規登録してください。

各種コード

  • NII論文ID(NAID)
    10021266439
  • NII書誌ID(NCID)
    AA10901436
  • 本文言語コード
    ENG
  • 資料種別
    ART
  • ISSN
    09188959
  • データ提供元
    CJP書誌  J-STAGE 
ページトップへ